1. Home
  2. ETW vs FNA Comparison

ETW vs FNA Comparison

Compare ETW & FNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETW
  • FNA
  • Stock Information
  • Founded
  • ETW 2005
  • FNA 2010
  • Country
  • ETW United States
  • FNA United States
  • Employees
  • ETW N/A
  • FNA N/A
  • Industry
  • ETW Investment Managers
  • FNA Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • ETW Finance
  • FNA Health Care
  • Exchange
  • ETW Nasdaq
  • FNA Nasdaq
  • Market Cap
  • ETW N/A
  • FNA 910.9M
  • IPO Year
  • ETW N/A
  • FNA 2021
  • Fundamental
  • Price
  • ETW $8.54
  • FNA $13.00
  • Analyst Decision
  • ETW
  • FNA Buy
  • Analyst Count
  • ETW 0
  • FNA 7
  • Target Price
  • ETW N/A
  • FNA $15.20
  • AVG Volume (30 Days)
  • ETW 284.6K
  • FNA 2.0M
  • Earning Date
  • ETW 01-01-0001
  • FNA 02-27-2025
  • Dividend Yield
  • ETW 8.61%
  • FNA N/A
  • EPS Growth
  • ETW N/A
  • FNA N/A
  • EPS
  • ETW N/A
  • FNA N/A
  • Revenue
  • ETW N/A
  • FNA $244,995,000.00
  • Revenue This Year
  • ETW N/A
  • FNA $18.70
  • Revenue Next Year
  • ETW N/A
  • FNA $14.47
  • P/E Ratio
  • ETW N/A
  • FNA N/A
  • Revenue Growth
  • ETW N/A
  • FNA 18.16
  • 52 Week Low
  • ETW $6.96
  • FNA $4.65
  • 52 Week High
  • ETW $8.49
  • FNA $14.79
  • Technical
  • Relative Strength Index (RSI)
  • ETW 51.04
  • FNA 78.72
  • Support Level
  • ETW $8.51
  • FNA $10.11
  • Resistance Level
  • ETW $8.67
  • FNA $13.04
  • Average True Range (ATR)
  • ETW 0.09
  • FNA 0.44
  • MACD
  • ETW 0.01
  • FNA 0.18
  • Stochastic Oscillator
  • ETW 57.58
  • FNA 97.02

About FNA Paragon 28 Inc.

Paragon 28 Inc is a medical devices company that develops, distributes, and sells medical devices in the foot and ankle segment of the orthopedic implant marketplace. Its products include plates and plating systems, screws, staples, and nails aimed to address all major foot and ankle procedures including ankle, Charcot, fracture fixation, hallux valgus, hammertoe, and flat foot. The company's suite of surgical solutions comprises nearly 80 product systems to help fit the specific needs of each patient and procedure. Geographically the company generates the majority of its revenue from the United States.

Share on Social Networks: